These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25600211)

  • 1. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J; Yang MS; Quan Y; Gueorguieva P; Ganesh T; Dingledine R
    Neurobiol Dis; 2015 Apr; 76():126-136. PubMed ID: 25600211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.
    Jiang J; Yu Y; Kinjo ER; Du Y; Nguyen HP; Dingledine R
    Neuropharmacology; 2019 May; 149():149-160. PubMed ID: 30763657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus.
    Rojas A; Ganesh T; Lelutiu N; Gueorguieva P; Dingledine R
    Neuropharmacology; 2015 Jun; 93():15-27. PubMed ID: 25656476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
    Jiang J; Quan Y; Ganesh T; Pouliot WA; Dudek FE; Dingledine R
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3591-6. PubMed ID: 23401547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
    Rojas A; Amaradhi R; Banik A; Jiang C; Abreu-Melon J; Wang S; Dingledine R; Ganesh T
    Neurotherapeutics; 2021 Apr; 18(2):1207-1225. PubMed ID: 33410110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
    Varvel NH; Espinosa-Garcia C; Hunter-Chang S; Chen D; Biegel A; Hsieh A; Blackmer-Raynolds L; Ganesh T; Dingledine R
    J Neurosci; 2021 Feb; 41(5):1105-1117. PubMed ID: 33293358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats.
    Rojas A; Ganesh T; Manji Z; O'neill T; Dingledine R
    Neuropharmacology; 2016 Nov; 110(Pt A):419-430. PubMed ID: 27477533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
    Jiang J; Ganesh T; Du Y; Quan Y; Serrano G; Qui M; Speigel I; Rojas A; Lelutiu N; Dingledine R
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3149-54. PubMed ID: 22323596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EP2 Receptor Signaling Regulates Microglia Death.
    Fu Y; Yang MS; Jiang J; Ganesh T; Joe E; Dingledine R
    Mol Pharmacol; 2015 Jul; 88(1):161-70. PubMed ID: 25715797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus.
    Nagib MM; Yu Y; Jiang J
    Pharmacol Ther; 2020 May; 209():107504. PubMed ID: 32088247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.
    Rojas A; Ganesh T; Wang W; Wang J; Dingledine R
    Neurobiol Dis; 2020 Jan; 133():104399. PubMed ID: 30818067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical development of an EP2 antagonist for post-seizure cognitive deficits.
    Varvel NH; Amaradhi R; Espinosa-Garcia C; Duddy S; Franklin R; Banik A; Alemán-Ruiz C; Blackmer-Raynolds L; Wang W; Honore T; Ganesh T; Dingledine R
    Neuropharmacology; 2023 Feb; 224():109356. PubMed ID: 36460083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase-associated malignant glioma growth.
    Qiu J; Li Q; Bell KA; Yao X; Du Y; Zhang E; Yu JJ; Yu Y; Shi Z; Jiang J
    Br J Pharmacol; 2019 Jun; 176(11):1680-1699. PubMed ID: 30761522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.
    Du Y; Kemper T; Qiu J; Jiang J
    Expert Rev Neurother; 2016; 16(2):123-30. PubMed ID: 26689339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective.
    Yasmen N; Sluter MN; Li L; Yu Y; Jiang J
    Mol Brain; 2023 Jan; 16(1):14. PubMed ID: 36694204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP2 receptor agonist ONO-AE1-259-01 attenuates pentylenetetrazole- and pilocarpine-induced seizures but causes hippocampal neurotoxicity.
    Santos AC; Temp FR; Marafiga JR; Pillat MM; Hessel AT; Ribeiro LR; Miyazato LG; Oliveira MS; Mello CF
    Epilepsy Behav; 2017 Aug; 73():180-188. PubMed ID: 28645087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin attenuates spontaneous recurrent seizures and inhibits hippocampal neuronal loss, mossy fiber sprouting and aberrant neurogenesis following pilocarpine-induced status epilepticus in rats.
    Ma L; Cui XL; Wang Y; Li XW; Yang F; Wei D; Jiang W
    Brain Res; 2012 Aug; 1469():103-13. PubMed ID: 22765917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.
    Yu Y; Li L; Nguyen DT; Mustafa SM; Moore BM; Jiang J
    Mol Neurobiol; 2020 Jun; 57(6):2830-2845. PubMed ID: 32378121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-1/-2, microsomal prostaglandin-E synthase-1 and E-prostanoid receptor 2 and regulation of inflammatory mediators by PGE(2) in the amoeboid microglia in hypoxic postnatal rats and murine BV-2 cells.
    Li P; Lu J; Kaur C; Sivakumar V; Tan KL; Ling EA
    Neuroscience; 2009 Dec; 164(3):948-62. PubMed ID: 19712723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.